Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
Ralf Bartenschlager(German Cancer Research Center), Takaji Wakita(National Institute of Infectious Diseases)
Cited by 169
Related Papers
Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras
|Proceedings of the National Academy of Sciences|2006|712
Three-Dimensional Architecture and Biogenesis of Membrane Structures Associated with Hepatitis C Virus Replication
|PLoS Pathogens|2012|514
Essential Role of Domain III of Nonstructural Protein 5A for Hepatitis C Virus Infectious Particle Assembly
|PLoS Pathogens|2008|444
Ultrastructural Characterization of Zika Virus Replication Factories
|Cell Reports|2017|369
SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB
|Communications Biology|2022|260